内镜下十二指肠乳头括约肌切开术治疗Oddi括约肌功能失调(附69例报告)  

Endoscopic sphincterotomy for treatment of sphincter of Oddi dysfunction(69 cases report)

作　　者：赵亚刚[1] 孙大勇[1] 周梅花[1] 曾海萍[1] 过利波[1] 

机构地区：[1]广州军区广州总医院消化内科,广东广州510010

出　　处：《中国内镜杂志》2007年第3期277-278,281,共3页China Journal of Endoscopy

摘　　要：目的观察内镜下十二指肠乳头括约肌切开术(EST)对胆囊切除术后Oddi括约肌功能失调(SOD)的疗效。方法根据患者病史、临床症状、ERCP检查及肝功能改能变等进行综合诊断,对诊断为SOD的92例患者先行内科药物治疗,有69例接受EST治疗。结果药物治疗总有效率为20.7%(19/92),EST治疗总有效率为92.8%(64/69),明显优于药物治疗(P<0.01)。结论对早期的轻症SOD患者,药物治疗是首选;对药物治疗失败者或中晚期的狭窄型SOD患者,EST是一种微创、安全和有效的治疗手段。[Objective] We made this research to observe the treatment effect of endoscopic sphineterotomy（EST） on patients with sphincter of oddi dysfunction （SOD） after cholecystectomy. [Method] 92 patients with SOD were diagnosed according to their history, clinical symptoms and report of ERCP and Hepatic function. At the begining all of them were treated with medicine, then 69 patients of those who were ineffective to medicine accepted EST. [Resuit] The effective rate of medicine was 20.7%（19/92）. The effective rate of EST was 92.8%（64/69）. The effective rate of EST was significantly higher than medicine （P 〈0.01）. [Conclusion] For early patients with slight SOD symptoms, medicine treatment should be their priority choice. But for those who were ineffective to medicine or pa- tients with SOD of stenosis type, EST might be the best choice for its safety and effectiveness.

关 键 词：奥狄括约肌功能失调 内镜/治疗 内镜下十二指肠乳头括约肌切开术 

分 类 号：R657.4[医药卫生—外科学]